Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2026-05-15 @ 4:26 PM
Study NCT ID:
NCT03454451
Status:
COMPLETED
Last Update Posted:
2023-12-21
First Post:
2018-02-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
Sponsor:
Corvus Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-Small Cell Lung Cancer | View |
| None | Renal Cell Cancer | View |
| None | Colorectal Cancer | View |
| None | Triple Negative Breast Cancer | View |
| None | Cervical Cancer | View |
| None | Ovarian Cancer | View |
| None | Pancreatic Cancer | View |
| None | Endometrial Cancer | View |
| None | Sarcoma | View |
| None | Squamous Cell Carcinoma of the Head and Neck | View |
| None | Bladder Cancer | View |
| None | Metastatic Castration Resistant Prostate Cancer | View |
| None | Non-hodgkin Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | NSCLC | View |
| None | RCC | View |
| None | TNBC | View |
| None | mCRPC | View |
| None | CRC | View |
| None | Lung Cancer | View |
| None | Kidney Cancer | View |
| None | Rectal Cancer | View |
| None | Breast Cancer | View |
| None | Sarcoma | View |
| None | Endometrial | View |
| None | Pancreatic | View |
| None | Ovarian | View |
| None | SCCHN | View |
| None | NHL | View |